GBT:EPA
Guerbet SA
€6.63
arrow_downward
-0.30%(-0.020) 1D
Oct 6, 1:35:05 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GBT...
Open
€6.65
High
€6.65
Low
€6.60
Mkt. cap
83.81M
Avg. vol.
10.89K
Volume
9.39K
52-wk high
€18.26
52-wk low
€6.60
EPS
-€11.05
Shares outstanding
12.64M
No. of employees
3K
Open
€6.65
High
€6.65
Low
€6.60
Mkt. cap
83.81M
Avg. vol.
10.89K
Volume
9.39K
52-wk high
€18.26
52-wk low
€6.60
EPS
-€11.05
Shares outstanding
12.64M
No. of employees
3K
News stories
From web sources and news partners
Business Wire
·
1 hour ago
Everspin Technologies to Ring Opening Bell in Celebration of 10-Year Nasdaq Anniversary
The Manila Times
·
35 minutes ago
ONAR Appoints Audit Chair Kelly Anderson, Former Public-Company CFO and Veteran of More Than 400 Acquisitions, as Interim Chief Financial Officer to Lead Nasdaq Uplist Preparation
Stock Titan
·
19 minutes ago
AI agents have no checkout path at 97 of America's 100 largest retailers
CNN
·
3 hours ago
Wall Street is booming. Surging yields could shake things up
Profile
Guerbet is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.
In 2017 Guerbet’s revenues were €807.1 million. It employs over 2,700 people worldwide and has manufacturing facilities in over 20 countries including France, Ireland, Canada, Macedonia, the United States and Brazil. The company’s headquarters is located in Villepinte, Seine-Saint-Denis.
In July 2015, Guerbet announced the takeover of a portion of Mallinckrodt's contrast media and application systems divisions. The acquisition was completed in November 2015.
In 2022, the United States Food and Drug Administration approved Guerbet Group's Elucirem, an MRI contrast agent. The product is produced at Guerbet's factory in Raleigh, North Carolina and at three of its French factories. Wikipedia
About Guerbet SA